Restricted kappa chain expression in early ontogeny: biased utilization of V kappa exons and preferential V kappa-J kappa recombinations by unknown
Restricted K Chain Expression in Early Ontogeny: 
Biased Utilization of  Exons and Preferential 
VrJK Recombinations 
By Carmen  A.  Medina  and Judy  M.  Teale 
From the Department of Microbiology, The University of Texas Health Science Center at 
San Antonio, San Antonig Texas 78284-7758 
Summary 
To determine the extent of ~ chain diversity in the preimmune repertoire early in development, 
~c cDNA libraries were analyzed from 15-d old fetal omentum, 18-d-old fetal liver, and 3-wk 
old bone marrow. An anchored polymerase chain reaction approach was used to avoid bias for 
particular V~ families. From the sequence analysis of 27 bone marrow clones, 10 different fami- 
lies and 20 unique V~ genes were identified.  In contrast, the V~ expression in the fetus is highly 
restricted and clearly differs from the broader distribution seen in 3-wk-old bone marrow. Al- 
though several V~ families were represented in the fetal library including V~9, V~10, V~4,5, V~8, 
and V~I, one or two members of individual families were observed repeatedly.  The fetal liver 
and omentum libraries  were found to be largely overlapping.  Given the V~ families/exons 
identified in the fetal sequences, the mechanism of K rearrangements in the early repertoire ap- 
pears to occur predominantly  by inversion. Importantly, the fetal repertoire was further restricted 
by dominant V~-J~ combinations such as V~4,5-J~5, V~9-J~4, and V~10-J~l. Since in some cases 
independent rearrangements could be established, the results indicate a bias for particular V~-JK 
joins. The results also suggest that clonal expansionAelection in the fetal repertoire takes place 
after light chain rearrangement as opposed to at the pre-B cell level in the bone marrow. The 
restriction observed in K light chain expression together with known restrictions in gene usage 
and junctional diversity at the heavy chain level indicate a remarkably conserved fetal repertoire. 
D 
iversity of the antibody repertoire is created by several 
genetic mechanisms. These include recombination of 
discrete DNA segments (V, D., J) that encode the variable 
region genes of both H and L chains, addition of nontemplated 
nucleotides during joining (N insertions), P additions, dele- 
tion of nucleotides during recombination, somatic mutation, 
and H and L chain pairing (for a review see reference 1). To- 
gether, such mechanisms allow for enormous repertoires with 
estimates of 107-109 different antibody specificities (1). 
Early in ontogeny, B lymphopoiesis  occurs in the fetal liver, 
bone marrow, spleen, and omentum, whereas in the adult, 
B cell generation occurs mainly in bone marrow (2-4). Early 
interest in the developing antibody repertoire focused on the 
reproducible patterned appearance of specificities, suggesting 
a  genetic program  (5,  6).  Subsequent  studies  revealed  a 
nonrandom use  of V.  gene  families  with  preference  for 
D-proximal families 7183 (7, 8) and Q52 (9). This contrasts 
with  the adult  where V.  family usage in bone marrow 
correlates with the complexity of the families in the germ- 
line (9, 10) suggesting distinct differences in mechanisms of 
diversity. Importantly, fetal B cell progenitors propagated on 
adult bone marrow stromal cells still gave rise to fetal-like 
V gene repertoires,  indicating that fetal B cell/progenitors 
are distinct from their adult counterparts (11). Accumulating 
evidence continues to support this hypothesis (12-15),  un- 
derscoring the importance of defining associated mechanisms 
and biological significance. 
Among murine antibodies,  ~ light chains dominate and 
therefore contribute significantly  to diversity (16). In the 
mouse, the K locus has been classified into 24 VK groups ac- 
cording to amino acid similarities up to Cys 23 (17). More 
recently,  14-16  VK families have been defined based  upon 
80% nucleotide similarity and RFLP analysis (18, 19). V~32, 
V,33,  and V~20 are among the new families described by 
several groups (20, 21). Importantly, up to 40% of the V~ 
genes appear to be in the opposite transcriptional orientation 
from J (22), and rearrangement by inversion appears to take 
place as efficiently as deletion mechanisms (23-26) that dom- 
inate H chain rearrangements.  Moreover, secondary V~ gene 
rearrangements are common and take place even when the 
initial rearrangement is a productive one (27, 28). Therefore, 
VK replacements may play a critical  role in increasing the 
diversity of V, gene usage. 
Comparative analyses of adult and fetal/neonatal V~ gene 
family usage have been done (29-31). No evidence was found 
for a bias in J-proximal families early in ontogeny. Among 
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fetal V~ family usage.  But, in general, the results were not 
dramatic and were somewhat conflicting in terms of differ- 
ences in expression  of particular families (29-31).  Much of 
the discrepancy probably relates to the early use of V~ family 
probes  containing the  more  conserved 3'  portions  of VK 
exons  resulting in detection of more than one family (32, 
33).  In  general,  VK families  are  more  homologous in  se- 
quence to each  other than V. families,  making VK family 
analyses by probe hybridization less reliable  (32). 
To address more definitively V~ usage early in ontogeny, 
eDNA libraries were constructed and analyzed from fetal liver, 
fetal omentum, and 3-wk-old bone marrow. An anchored 
PCR was used to minimize bias and allow for the detection 
of all  V~  gene families.  The  results  indicate a  consistent 
preference during fetal life for a small set of V~ exons from 
multiple families. Diversity appeared to be further restricted 
by the repeated use of particular V~-J~ combinations. 
Materials and Methods 
Mice.  A]] experiments were performed with BALB/c  mice ob- 
tained from Sprague-Dawley, Inc. (Indianapolis,  IN). Animals were 
bred and maintained at the animal  facility  of the University of  Texas 
Health Science  Center and were routinely evaluated  for pathogens. 
Livers from four 18-d-old  fetuses were pooled. Omental tissue was 
obtained from a pool of six 15-d-old fetuses. The gestational age 
was determined by considering the day of mating as day 0 or by 
the presence of vaginal plugs. Extreme care was taken when dis- 
secting the omentum to avoid  contamination from spleen or liver. 
Furthermore, tissues were transferred  multiple times to petri plates 
containing flesh solutions of BSA in HBSS to avoid carry-over of 
individual contaminating cells. Bone  marrow cell suspensions were 
prepared from the femurs and tibias of 3-wk-old mice. Cells from 
three animals were pooled. 
Preparation of  eDNA Libraries.  Total  cellular RNA was isolated 
from tissues by lysis  with guanidinium isothiocyanate  followed  by 
centrifugation over a cesium chloride gradient. First strand eDNA 
was generated using reverse transcriptase (SuperScript RNase H-; 
GIBCO BRL, Gaithersburg, MD) and oligo-dT priming. Unin- 
corporated nucleotides and primers were removed from the reac- 
tion mixture by separation through columns (Elutip-d; Schleicher 
& Schuell, Inc., Keene, NH). Instructions provided  by the manufac- 
turer were followed  except that all the solutions  were prepared using 
potassium salts, as sodium is known to inhibit terminal  deoxynucleo- 
tide  transferase (TdT)  1 activity. RNA-DNA  hybrids were dis- 
rupted by alkaline  hydrolysis  with 0.2N KOH followed  by neutral- 
ization with 1 N HCI. Poly-dG tailing of the eDNA molecules 
using TdT (Stratagene, La Jolla, CA) was performed as described 
by Roth et al. (34). After phenol-chloroform  extraction of  the reac- 
tion mixture, DNA was precipitated, resuspended in 0.1  x  TBE 
and used as template for PCR. 
PCR Amplification, Clonin~ and Sequencing.  PCK was performed 
in 51Y/A reactions  containing  2.5 U Taq polymerase  (Promega  Corp., 
Madison, WI), 1.5 mM MgC12, 50 mM KC1, 0.01% gelatin, 25 
pmole of each primer (Genosys  Biotechnologies,  Inc., The Wood- 
hnds, TX), and 5 #1 of  each eDNA template. To prevent  mispriming 
events, all the components were added to the reaction except the 
1  Abbreviation used in this paper: TdT, deoxynucleotide  transferase. 
polymerase. After one cycle of 7 rain at 95~  the temperature 
of the thermocycler was lowered to 72~  At this time, 2.5 U of 
the Taq polymerase was added to each reaction and samples were 
overlaid with 50 gl of mineral oil. The samples were subjected to 
30 cycles  of I min at 94~  2 min at 47~  and 1.5 min at 72~ 
All PCR were terminated  with a 15-rain extension.  Extreme  precau- 
tions were taken to prevent contamination. All reactions were car- 
ried in a laminar hood, and equipment and tubes were UV irradi- 
ated.  Mock  samples that were subjected to  all the  enzymatic 
treatments served as negative controls. 
The sequences of the primers used in the amplifications were 
as follows: 5'  end,  5'-CAC-GAT-CCG-CGG-TGC-CCC-CCC- 
CCC-CCC-3';  3' end, 5'-CAC-CAT-ATC-G~TG-GTG-CAA- 
CAT-CAG-3'. To facilitate  cloning, the primer at the 5' end included 
a SaclI restriction site and the one at the 3' end (C  0  a ClaI site. 
PCR bands were resolved in 1% agarose gels and the appro- 
priate size  products were eafised. DNA was eluted from the agarose 
gels by centrifugal membrane filtration  through 0.45-gm  low 
binding membranes (Durapore; Millipore Corp., Bedford, MA). 
Agarose contaminants were removed  by treatment with glass milk 
(Bin 101, Inc., Vista, CA). Purified fragments were cloned into 
p-Bluescript SK-vector (Stratagene) using the SaclI and ChI re- 
striction sites. DH5o~F' or DHllS competent cells (GIBCO BILL) 
were transformed  with the ligation  reaction and plated  onto nitrocel- 
lulose filters. 
To screen for positive clones, a consensus  JK and the C, primer 
used in the amplifications were endlabeled with [32p]ATP using 
T7 polynucleotide  kinase  (New England  Biolabs, Inc., Beverly,  MA). 
Double  positive (J,+,  C, +)  clones were expanded, and  single 
stranded DNA obtained by superinfection with M13K07 helper 
phage (GIBCO BRL). DNA sequencing was performed using the 
dideoxy nucleotide termination method with Sequenase 2 (United 
States Biochem. Corp., Cleveland, OH). 
Sequence Analysis.  Nucleic  acid similarities  between sequences 
in GenBank and EMBL data banks and our sequences were deter- 
mined using the FASTDB program (35). 
Results and Discussion 
Multiple  Vx Exons Are Expressed in 3-wk-old Bone Marrow. 
To evaluate the expressed repertoire of K light chains,  bone 
marrow was pooled from three 3-wbold BALB/c mice. Im- 
munocytochemical staining with anti-Ig showed that the 
proportion of plasma cells in the cell preparation was very 
low (<0.1%).  3 wk of age was chosen since it was antici- 
pated from previous  V.  gene analyses  that the repertoire 
would be mostly adultlike with the possibility for some overlap 
with the early repertoire,  eDNA templates were amplified 
using anchored PCR to avoid bias  for particular V~ fami- 
lies. V~-J, rearrangements were identified after cloning and 
sequencing of the amplified eDNA fragments. All of the rear- 
rangements analyzed appeared  to be productive ones. The 
data are summarized in Table 1. Clones representing prob- 
able independent rearrangements are listed separately. If two 
or fewer substitutions were found between individual clones 
they were grouped as identical since two substitutions ap- 
proximated the error calctdated for the Taq polymerase. An 
exception to this was when an identical substitution was found 
in more than one clone or a different library making an error 
with the Taq polymerase unlikely. In this case, the dones 
were considered as independent rearrangements. 
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Clone  VK  J~  Frequency  Percent match  Specificity  Reference 
BM-17N  4,5  1  1/27  99.6" 
(84.CON)# 
BM-12  4,5  1  1/27  100 
(R9) 
BM-6  4,5  1  1/27  98.9 
(H3, CH5) 
BM-2n  4,5  4  1/27  99.3 
(76.CON) 
BM-10n  4,5  2  1/27  99 
(R13) 
BM-10  4,5  5  2/27  100 
BM-41  (H4, T6-416) 
BM-Sn  8  1  1/27  100 
(T5-626) 
BM-29  8  2  1/27  99.7-100 
(220GL, NC12-H5, PC3609) 
BM-23n  8  2  2/27  98.3 
BM-15  (MRB2) 
BM-11  8  5  1/27  100 
(M603) 
BM-46  1  1  1/27  99.7 
(VA.6,  DNA14, 42-4B-12, 
1210.7) 
BM-8n  23  2  1/27  99.3 
(V~23.32) 
BM-36  23  1  1/27  84.6 
(V~23.32) 
BM-4n  20  5  1/27  100 
(C8.5) 
BM-26n  20  2  1/27  99.6 
(33.28) 
BM-1  19  5  1/27  99.6 
(PC7043) 
BM-21N  21  5  1/27  99.0-99.7 
(V~21 El.6, BrM8) 
BM-3  32  1  1/27  99.6-99.3 
(AN04K, NC6-C8) 
BM-16  10  1  2/27  99.6-100 
BM-37  (KL2.21,  CH12) 
BM-9  9  1  1/27  99.3-99.6 
(MOPC41,  $2-14.2,  H220-23) 
BM-8  9  1  2/27  99.3-99.6 
BM-18  (MOPC41,  $2-14.2,  H220-23) 
BM-30  9  2  1/27  99.6-100 
(MOPC41,  $2-14.2,  H220-23) 
BM-16a  9  4  1/27  99.6-99.3 
(MOPC41,  $2-14.2,  H220-23) 
Germline  V,OxS 
Germline.  V,Ox 
Germline  V~Ox 
Germline.  V~Ox 
Germline  V,Ox 
Germline  V,Ox, 
Hemagglutinin 
Hemagglutinin 
Hemagglutinin 
Plasmacytoma 
Histone 
PC 
Germline,  DNA,  dextran, 
Arsonate 
Germline 
Germline 
DNA 
Colon-carcinoma antigen 
Plasmacytoma 
Germline,  muhireactive 
DNP 
Germline,  V~Arslt, 
Muhireactive 
Germline,  RBC and T  cells, 
Hemagglutinin 
Germline,  RBC and T  cells, 
Hemagglutinin 
Germline,  RBC and T  cells, 
Hemagglutinin 
Germline,  RBC and T  ceils, 
Hemagglutinin 
36 
54 
54,  39 
36 
54 
54, 49 
49 
55,  56, 25 
57 
58 
31,  59 
31 
31 
21 
6O 
25 
61, 62 
20,  56 
63,  64, 39 
65, 66, 67 
65, 66,  67 
65, 66,  67 
65, 66, 67 
" Percent homology through the coding regions of the variable gene. 
t Germline gene designation or hybridoma or cell line from which the gene was cloned and/or sequenced. 
S  Anti-2-phenyloxazolone-related  germline gene. 
II Antiarsonate-related germline gene. 
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BM-17n 
BM-12 
BM-6 
BM-2n 
BM-10n 
BM-10 
-I0  I0 
M  D  F  Q  V  Q  I  F  S  F  L  L  I  S  A  S  V  I  M  S  R  G  Q  I  v  L  T  Q  S  P  A  I 
GAG  AAA  ATG  GAT  TTT  CAG  GTG  CAG  ATT  TTC  AGC  TTC  CTG  CTA  ATC  AGT  GCC  TCA  GTC  ATA  ATG  TCC  AGA  GGA  CAA  ATT  GTT  CTC  ACC  CAG  TCT  CCA  GCA  ATC 
--C  .........................................................  C  ......................................... 
--C  ..............  A  ............................................  A  ............  G  .......................... 
--C  ......  C  .......  A  .................................................................................... 
T-C  -C  ...........................................  AT  ......  T  G  ..............  G--  -A-  --G  ..................... 
--C  -G  ................................................................................................. 
VK8  M  E  S  Q  T  Q  V  F  L  S  L  L  L  W  v  S  G  T  C  G  N  I  M  M  T  Q  S  P  S  S 
BM-5n  AGG  GGG  ATC  AAG  ATG  GAA  TCA  CAG  ACT  CAG  GTC  TTC  CTC  TCC  CTG  CTG  CTC  TGG  GTA  TCT  GGT  ACC  TGT  GGG  AAC  ATT  AT(} ATG  ACA  CAG  TCG  CCA  TCA  TCT 
BM-29  .....  A  -G  .........  T  ......  G-C  .....  T  C-T A-G  -TA  ....  C-  --A .....................  G  .....  G  .....  T  .......  T  ..... C  --C 
BM-23n  --T  .... G  .........  T  ......  G-C  .....  T  C-- A-A  -TG  ........  A  .....................  G  .....  G  .....  T  .......  T  .....  C  --C 
BM-II  ---  T--  -G  .........................  C-- A .....  T  .....  T  .......................  G  .....  G  .............  T  .....  C  --C 
VKI  M  M  S  P  A  Q  F  L  F  L  L  V  L  W  I  R  E  T  N  G  D  V  V  M  T  Q  T  P  L  T 
BM-46  CAT  TTC  CTC  AAA  ATG  ATG  AGT  CCT  GCC  CAG  TTC  CTG  TTT  CTG  TTA  GTG  CTC  TGG  ATT  CGG  GAA  ACC  AAC  GGT  GAT  GTT  GTG  ATG  ACC  CAG  ACT  CCA  CTC  ACT 
VK23  M  V  S  T  S  Q  L  L  G  L  L  L  F  W  T  S  A  S  R  C  D  I  V  M  T  Q  S  P  A  T 
BM-Sn  GAA  AAT  TTG  AAG  ATG  GTG  TCC  ACT  TCT  CAG  CTC  CTT  GGA  CTT  TTG  CTT  TTC  TGG  ACT  TCA  GCC  TCC  AGA  TGT  GAC  ATT  GTG  ATG  ACT  CAG  TCT  CCA  GCC  ACC 
~4-36  ....  GC  --A  ........  A  -T-  --A  C  ....  T  A  ...........  C  ............  T  ...........  C-  G  .......  C  C--  C  ....  C  ............... 
VK20  M  T  M  F  S  L  A  L  L  L  S  L  L  L  L  C  V  S  D  S  R  A  E  T  T  v  T  Q  S  P  A  S 
BM-4n  AAG  GCC  ATG  ACC  ATG  TTC  TCA  CTA  GCT  CTT  CTC  CTC  AGT  CTT  CTT  CTC  CTC  TGT  GTC  TCT  GAT  TCT  AGG  GCA  GAA  ACA  ACT  GTG  ACC  CAG  TCT  CCA  GCA  TCC 
BM-26n  G-A  ............  C  ............  C  .........  C  ............................................................... 
~19  MGIKMESQTQVFVYMLLWLSGVDGDIVMTQSQKF 
BM-~A~G~ATC~GATGGAG~ACAGACT~GG~T~GTATACATG~GC~TGGTTGTCTGGTGTT~T~AGACA~GTGATGACCCAGTCT~ 
VK21  METDTLLLWVLLLWVPGSTGDIVLTQSPAS 
BM-21n  ~GA~GAGACA~CACACT~C~TAT~G~CTGCTGC~TGGG~C~GGTT~CA~T~TGACA~GTGCTGACA~AGTCTCCTGCTTCC 
VK32  MRVLAELLGLLLFCFLGVRCDIQMNQSPSS 
~-3TACACCATCA~ATGAGG~C~T~GC~CTGGGGC~CTG~TGT~T~TTTTTAGGTGTGAGATGTGACATCCAGATG~CAGTCT~ATC~AGT 
VKI0  MMSSAQFLGLLLLCFQGTRCDIQMTQTTSS 
~-~6CT~AGCCTGCACA~ATG~CTCTGCT~G~CC~GGTC~CTG~G~TTTT~GGTACCAGATGTGATATCCAGATGACACAGA~TA~A~CTCC 
~-37  .........................................  T  ............................................................ 
VK9 
BM-9 
BM-18 
BM-8 
BM-30 
BM-16a 
MDMRAPA~IFGFLLLLFPGTRCDIQMTQSPSS 
C~  AGC  ATG  CAC  A~  AGG  ~T  CCT  ~A  G  A~  T~  ~C  ~  ~G  TTG  C~  ~G  TTT  CCA  GGT  ACC  AGA  ~T  GAC  AT  CAG  ATG  ACC  CAG  TCT  CCG  TCC  TCC 
...............................................................................................  A  ...... 
...............................................................................................  A  ...... 
...............................................................................................  A  ...... 
............................................................................................  A  ...... 
VK4,5  CDRI" 
20  27 
MSASLGEEITLTCSASSSVSYMH  WY~ 
~-17n  ATG  TCT  ~A  ~T  CTA  GGG  CAG  GAG  ATC  ACC  CTA  ACC  TGC  AGT  ~C  A~  TCG  AGT  GTA  AGT  TAC  ATG  ~C  ***  ***  ***  ***  ***  ***  ***  TGG  TAC  C  G  C  G 
~-12  .............  C  .......  A--  G  .....  A-G  .................  A  --~  A ..............  ***  ***  ***  ***  ***  ***  ***  ............ 
~-6  .............  C  .......  A--  G  .....  A-G  .................  A  ..................  ***  ***  ***  ...  ***  ***  ***  ............ 
BM-2n  .............  C  .......  A--  G  .....  A ...................  A  ..................  ***  ***  ***  ***  ***  ***  ***  ....  T  ....... 
~-10n  .....................  A--  G  .....  A-G  -G  ......  G  ........  A  .......  A-  --T  ---  T--  ***  ***  ***  ***  ***  ***  ***  ............ 
~-I0  .............  C  .......  A--  G  .....  A--  T  ................  A  ...............  T--  ***  ***  ***  ***  ***  ***  ***  ............ 
VK8  L  A  V  S  A  G  E  K  V  T  M  S  C  K  S  S  Q  S  V  L  Y  S  S  N  Q  K  N  Y  L  A  W  Y  Q  Q 
BM-5n  CTG  GCT  GTG  TCT  GCA  GGA  GAA  AAG  GTC  ACT  ATG  AGC  TGT  AAG  TCC  AGT  CAA  AGT  GTT  TTA  TAC  AGT  TCA  AAT  CAG  AAG  AAC  TAC  TTG  GCC  TGG  TAC  CAG  CAG 
BM-29  --A  ........  A  -TT  .....  G  .....  T  ...........  C  ...........  G  --C  C  .......  T  ---  AGC  .....  A  ........................... 
BM-23n  ...........  A  ........  G  .................  C  --A  ........  G  ---  C-G  C-C  A  .....  AG-  -CC  .................  T  ............ 
BM-II  ---  AG  ......  A  ........  G  .................  C  ...........  G  ---  C-G  ---  A  .....  GG  ......  A  ........................... 
VKI  L  S  V  T  I  G  H  P  A  S  I  S  C  K  S  S  Q  S  L  L  D  S  D  G  K  T  Y  L  N  W  L  L  Q 
BM-46  TTG  TCG  GTT  ACC  ATT  GGA  CAT  CCA  GCC  TCC  ATC  TCT  TGC  AAG  TCA  AGT  CAG  AGC  CTC  TTA  GAT  AGT  GAT  GGA  AAG  ACA  TAT  TTG  AAT  ***  TGG  TTG  TTA  CAG 
VK23  L  S  V  T  P  G  D  R  V  S  L  S  C  R  A  S  Q  S  I  S  D  Y  L  H  W  Y  Q  Q 
BM-Sn  ~  TCT  GTG  ACT  CCA  GGA  CAT AGA  GTC  TCT  CTT  TCC  TGC  AGG  C-CC  AGC  CAG  AGT  ATT  AGC  GAC  TAC  q~fA  CAC  ***  ***  ***  ***  ***  ***  TGG  TAT  CAA  CAA 
BM-36  ....................  A  -C  ....  AG  .........  T  ..................  TA-  A-G  A--  C  .....  ***  ***  ***  ***  ***  "*~  ...........  G 
VK20  L  S  M  A  I  G  E  K  V  T  I  R  C  I  T  S  T  D  I  D  D  D  M  N  W  Y  Q  Q 
BM-4n  CTG  TCC  ATG  GCT  ATA  GGA  GAA  AAA  GTC  ACC  ATC  AGA  TGC  ATA  ACC  AGC  ACT  GAT  ATT  GAT  GAT  CAT  ATG  AAC  ***  ***  ***  ***  ***  ***  TGG  TAC  CAG  CAG 
BM-26n  ......  G  ......  C  ...............  T  ..........................................  ***  ***  ***  ***  **"  ***  ............ 
VKI  9  M  S  T  S  V  G  D  R  V  S  V  T  C  K  A  S  Q  N  V  G  T  N  V  A  W  Y  Q  Q 
BM-I  ATG  TCC  ACA  TCA  GTA  GGA  GAC  AGG  GTC  AGC  GTC  ACC  TGC  AAG  GCC  AGT  CAG  AAT  GTG  C-GT  ACT  AAT  GTA  GCC  ***  ***  ***  ***  ***  ***  TGG  TAT  CAA  CAG 
VK21  L  A  V  S  L  G  Q  R  A  T  I  S  C  R  A  S  Q  S  V  S  T  S  S  Y  S  Y  M  H  W  Y  Q  Q 
BM-21n  TTA  C-CT  GTA  TCT  CTG  GGG  CAG  AGG  GCC  ACC  ATC  TCA  TGC  AGG  GCC  AGC  CAA  AGT  GTC  AGT  ACA  TCT  AGC  TAT  AGT  TAT  ATG  CAC  ***  ***  TGG  TAC  CA2&  CAG 
VK32  L  S  A  S  L  G  D  T  I  T  I  T  C  H  A  S  Q  N  I  N  V  W  L  S  W  Y  Q  Q 
BM-3  CTG  TCT  GCA  TCC  CTT  GGA  GAC  ACA  ATT  ACC  ATC  ACT  TGC  CAT  GCC  AGT  CAG  AAC  ATT  AAT  GTT  TGG  TTA  AGC  ***  ***  ***  ***  ***  *"*  TGG  TAC  CAG  CAG 
VKI  0  L  S  A  S  L  G  D  R  V  T  I  S  C  R  A  S  Q  D  I  S  N  Y  L  N  W  Y  Q  Q 
BM-16  CTG  TCT  GCC  TCT  CTG  GGA  GAC  AGA  GTC  ACC  ATC  AGT  TGC  AGG  GCA  AGT  CAG  GAC  ATT  AGC  AAT  TAT  TTA  AAC  ***  ***  ***  ***  ***  ***  TGG  TAT  CAG  CAG 
BM-37  ........................................................................  ***  ***  ***  ***  ***  ***  ............ 
v~9 
BM-9 
BM-18 
BM-8 
BM-30 
BM-16a 
LSASLGERVSLTCRASQDIGSSLN  WLQQ 
~A  ~T  ~C  ~TCTG  ~AGAAAGAGTCAGTC~  ACTTGTC~  ~AAGTCAGGACATTGGTAGTAGC  ~A  ***********************--****** 
.......................  G  ................................................  ***  ***  ***  ***  ***  ***  ............ 
........................................................................  ***  ***  ***  ***  ***  ***  ............ 
........................................................................  ***  ***  ***  ***  ***  ***  ............ 
........................................................................  ***  ***  ***  *.*  ***  ***  ............ 
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~-l?n 
BN-12 
EM-6 
BM-2n 
~M-10n 
BM-10 
v@ 
~M-Sn 
E~/-29 
I~-23n 
I~4-11 
vK1 
BM-46 
vK23 
1~-Sn 
BM-36 
VK20 
BM-4n 
BM-26n 
VKI9 
RM-I 
VK21 
BM-21n 
VK32 
BM-3 
VKI0 
BM-16 
BM-37 
v~9 
BM-9 
BM-18 
~4-8 
BM-16a 
VK4,5 
40  50  60  70 
K  S  O  T  S  P  K  h  L  I  Y  S  T  S  N  h  A  S  G  V  P  S  R  F  S  G  S  G  S  G  T  u  Y  S 
AAG  TCA OOC ACT TL'T CCC AAA  CTC TTG ATT TAT AGe IgCA TCC KAC CTO GeT TCT GGA  GTC C~  ~  ~  ~  A~  ~  A~  ~  ~  ~  A~  ~  TAT ~ 
--- C  .......  C  --C ......  ~  -G  .......  GA  .........  A  ..................  G-  ............................  -C  ....... 
...........  C  --C .....  G  AGA  -O  .......  GA  .........  A  ..................  O  .............................  -C-  --C --- 
--- C  .....................  C  .....................................  G  ..............................  C-  --C --- 
.......  AT G-C  --C ........  A  -O  .......  TA  ................  C  ..........  A  O  ...........................  A-  -C  ....... 
--- C  .... A  T-C T-C  .......  C-  -G  .......  CG  ............................  G  ..............................  C-  --C  --- 
K  P  G  Q  S  P  K  b  L  I  Y  W  A  S  T  R  R  S  G  V  P  D  R  F  T  G  S  G  S  G  T  D  F  T 
AAA  CCA GGG CAG TCT CCT AAA CTG CTO ATC TAC "PGG GCA TCC ACT AGG GAA TCT GGT  GTC CCT GAT  CGC TTC ACA  GGC AGT  GOA TCT GGG ACA  OAT  TTT ACT 
.............................  T  ..........................  O  .........................................  C  --- 
........  A  ...............................................  G  .........................................  C  -  -  - 
............  C  ...........  T  ........  G  ......................  G  ...............................  A  --C  .....  C  --- 
R  P  G  Q  S  P  K  R  L  I  Y  L  V  S  K  L  D  S  G  V  P  D  R  F  T  G  S  G  S  G  T  D  F  T 
AGG  CCA  GGC CAG TCT CCA AAG CGC CTA ATC  TAT CTG  GTG TCT AAA CTG GAC TCT GGA  GTC CCT GAC AGG TTC ACT  GGC AGT  GGA TCA GGG ACA  GAT TTC ACA 
K  S  H  E  S  P  R  5  L  I  K  Y  A  S  Q  S  I  S  G  I  P  S  N  F  S  G  S  G  S  G  S  D  F  T 
AAA  TCA CAT GAG TCT CCA AGG CTT CTC ATC AAA  TAT GCT TCC CAA TCC ATC TCT GGG ATC CCC TCC AGG TTC AGT  GGC AGT GGA TCA GGG TCA  GAT  TTC ACT 
.........  CG  .....................  O  ........  T  G-T  ............................  C  ................  A  ......  A .... 
K  P  G  E  P  P  K  h  h  I  S  E  G  N  T  L  R  P  G  V  P  S  R  F  S  S  S  G  Y  G  T  D  F  V 
AAG  CCA GGG GAA CCT CCT AAG  CTC CTT ATT TCA GAA  GGC AAT ACT CTT CGT CCT GGA GTC CCA TCC CGA TTC TCC AGC AGT  GGC TAT GGT ACA  CAT TTT  GTT 
.........................................................................................  C  ........... 
K  P  G  Q  S  P  K  A  L  I  Y  S  A  S  Y  R  Y  S  G  V  P  D  R  F  T  G  S  G  S  G  T  D  F  T 
AAA  CCA GGG CAA TCT CCT A~  C-CA CTG AFT TAC TCG  GCA TCC  TAC eGG TAC AGT GGA  GTC CCT OAT CGC TTC ACA  GGC AGT  GGA TCT GGG ACA  CAT TTC ACT 
K  P  G  Q  P  P  K  h  h  I  K  Y  A  S  N  L  E  S  G  V  P  A  R  F  S  G  S  G  S  G  T  D  F  T 
AAA  CCA ~GA CAG CCA CCC AAA CTC CTC ATC AAG TAT  GCA TCC AAC CTA GAA TCT GGG  GTC CCT GCC AGG TTC AGT  GGC AGT GGG TCT GGG ACA  GAC TTC ACC 
K  P  G  N  I  P  K  L  L  I  Y  K  A  S  N  L  H  T  G  V  P  S  R  F  S  G  S  G  S  G  T  O  F  T 
AAA  CCA GGA AAT ATT CCT AAA CTA TTG ATC TAT AAG  GeT  TCC AAC TTG CAC ACA GGC  GTC CCA TCA AGG  TTT AGT  GGC AGT GGA  TCT GGA ACA  GGT TTC ACA 
K  P  D  G  T  V  K  L  L  I  Y  Y  T  S  R  L  H  S  G  V  P  S  R  F  S  G  S  G  S  G  T  D  Y  S 
AAA  CCA GAT GGA ACT GTT AAA CTC CTG ATC TAC  TAC ACA  TCA AGA TTA CAC TCA GGA  GTC CCA TCA AGG TTC AGT  GGC AGT  GGG TCT GGA ACA  GAT  TAT TCT 
...........  G  .......................................................................................... 
E  P  D  G  T  I  K  R  L  I  Y  A  T  S  S  L  D  S  G  V  P  K  R  F  S  G  S  R  S  G  S  D  Y  S 
GAA  CCA GAT GGA ACT ATT AAA CGC CTG ATe TAC GCC ACA  TCC AGT TTA GAT TCT GGT  GTC CCC AAA  AGG TTC AGT  GGC AGT AGG  TCT GGG TCA  GAT  TAT TCT 
...................................................................................................... 
...................................................................................................... 
...................................................................................................... 
..................................................................................................... 
CDR3- 
80  95 
LTISSVEAEDAADYYCHQWSSY  RTFG 
~-17n  CTCACAATCAGCAGTGTG  ~G  ~TG~  GATGCTGCCGATTATTACT~  CATCAOTGGAGTAGTTAT*'****C~  ACGTTC~T  Jkl 
~-12  ..............  C  A  ....................  AC  ................  C  ..........  C  CCA  *** T  ...........  Jkl 
~-6  ..............  CA ...................  TAC  ............  G  ...........  A-CC~  ***T  ...........  Jkl 
~-2n  ............  C-A A ...................  AC  ............  G  --A A .........  C  CCA  *** TTC  ........  C  Jk4 
~-10n  ..............  C  A  ......  G  .............  AC  ............  G  .... TT  -C  .....  CC CCA  *** TAC  ........  A  Jk2 
~-i0  ..............  C  A ....................  AC  ............  G  .... AT CA  ......  C  ~A  ***  -TC  .........  Jk5 
VK8  L  T  I  S  S  V  Q  A  E  D  L  A  V  Y  Y  C  H  Q  Y  b  S  S  W  T  F  G 
BM-hn  CTT ACC ATe  AGC AGT  GTA CAA GeT GAA GAC CTG GCA GTT  TAT TAC TGT  CAT CAA TAC CTC TCC TCG  ***  *** TGG ACG TTC GGT  Jkl 
BM-29  --C  ..............  G  A-G  .............................  G  .....  T  TAT AG-  -AT CCG  ***  -AC  ........  A  Jk2 
BM-23n  --C  ..............  G  --G  ..........................  C  A-G  .... CT  ---  ***  ***  ***  *** AAC  ........  A  Jk2 
BM-II  .................  G  --G  .............................  G  A-T  G-T  -AT AGT  -AT CCG  ***  CTC  ......  C--  Jk5 
VKI  L  K  I  S  R  V  E  A  E  D  h  G  V  y  Y  C  W  Q  G  T  H  F  P  R  T  F  G 
BM-46  CTG AAA ATe  AGC AGA  GTG GAG GCT GAG GAT TTG GGA GTT  TAT TAT TGC  TGG CAA GGT ACA CAT TTT CCT  *** CGG ACG  TTC COT  Jkl 
VK23  L  S  I  N  S  V  E  P  E  D  V  G  V  y  Y  C  Q  N  G  H  S  F  P  Y  T  F  G 
BM-8n  CTC AGT ATC  AAC AGT  GTG  GAA CCT GAA GAT GTT GGA GTG  TAT TAC TGT  CAA AAT GGT  CAC AGC TTT CCG  *** TAC ACG  TTC GGA  Jk2 
BM-36  ..................  A-G  --C .......  AA  --- A-A  ..........  TT C-A  --- T--  G-  ACA  --T *** TGG  ........  T  Jkl 
VK20  F  T  I  E  N  M  L  S  E  D  V  A  D  Y  Y  C  L  Q  S  D  N  L  P  L  T  F  G 
BM-4n  TTT ACA ATT  GAA AAC ATG  CTC TCA GAA GAT G'P? GCA GAT  TAC TAC TGT  TTG CAA AGT  GAT AAC TTG  CCT  *** CTC ACG  TTC GOT  Jk5 
~4-  26n  ................  C  ....  C  .........................................  A .....  ***  ...........  A  dk2 
VKI9  L  T  I  S  N  V  Q  S  E  D  L  A  E  Y  F  C  Q  Q  Y  N  S  Y  P  L  T  F  G 
BM-I  CTC Ace  ATC  AGC AAT  GTG  CAG TCT GAA GAC TTG GCA GAG  TAT TTC TGT  CAG CAA TAT AAC AGC TAT CCT  ***  CTC ACG TTC GGT  Jk5 
VK21  h  N  I  H  P  V  E  g  E  D  T  A  T  N  Y  C  Q  H  S  W  E  I  P  L  T  F  G 
BM-21n  CTC AAC ATC  CAT CCT GTG  GAG GAG GAG GAT ACT  GCA ACA  AAT TAC TGT CAO CAC AOT  TGG GAG ATC  CCG ***  CTC ACG  TTC GGT  Jk5 
VK32  L  T  I  S  S  L  Q  P  E  D  I  A  T  Y  Y  C  Q  Q  G  Q  S  Y  P  W  T  F  G 
BM-3  TTA ACC ATC  AGe AGC  CTG  CAG CCT GAA GAC ATT  GCC ACT  TAC TAC TGT  CAA CAG GGT  CAA AGT TAT eGG  *** TGG ACG  TTC GOT  Jkl 
VKI0  L  T  I  S  N  L  E  Q  E  D  I  A  T  Y  F  C  Q  Q  G  N  T  L  W  T  F  G 
BM-16 
BM-37 
CTC ACC ATT  AGC AAC  CTG  GAG CAA GAA GAT ATT GCC ACT  TAC TTT TGC  CAA CAG GGT AAT ACG CTG  ***  *** TGG ACG  TTC GGT  Jkl 
..................................................................  ***  ***  ......  C  .....  Jkl 
VK9  L  T  I  S  S  L  E  S  E  D  F  V  D  Y  Y  C  L  Q  Y  A  S  S  P  W  T  F  G 
BM-9  CTC ACC  ATC  AGC  AGC  CTT GAG TCT GAA GAT TTT GTA GAC  TAT TAC TGT CTA CAA TAT  GCT AGT TCT CCG  *** TGG ACG TTC GGT  Jkl 
BM-18  ....................................................................  T  *** C  ...........  Jkl 
BM-8  ....................................................................  T  *** C  ...........  Jkl 
BM-30  ....................................................................  G  ***  -AC  ........  A  Jk2 
BM-16a  ....................................................................  C  CCA  -TC  ........  C  Jk4 
Figure  1.  Nucleotide sequences of bone marrow K clones. Sequences are grouped according to V. gene family and are shown relative to one member 
of the family. (---) Identity.  (*) Gaps were introduced to fadlitate alignment of the sequences. The deduced amino add sequences for the representative 
member of each family is numbered  according  to Kabat et al. (69) and the locations  of CDRs are shown.  Sequence data for BM36  and Fb31 are 
available from EMBL under accession numbers  Z17400 and Z17401, respectively. Table 2.  Summary of  j,  utilization 
cDNA library  No. sequences  analyzed 
Percent  sequences  expressing 
J,1  J~2  J~4  J~5 
3-wk-old bone marrow  27 
Fetal liver  26 
Omentum  22 
44.4*  25.9  7.4  22.2 
30.8  7.7  34.6  26.9 
40.9  4.5  18.2  36.4 
" Data  taken from Tables 1, 3, and 4. 
The data in Table 1 reveals a pattern of considerable V~ 
sequence diversity. In all, 10 different families and 20 unique 
V~ genes were identified among the 27 clones sequenced. 
Even though the presence of plasma cells cannot be ruled 
out, their contribution appears minimal based upon the fre- 
quency of independent rearrangements  and the diversity of 
V, exons found. Some of the same V~ genes identified have 
been previously described for LPS-stimulated bone marrow 
cells (29, 30) and bone marrow pre-B cell lines (31). Rear- 
rangements involving identical V~ genes but different Jr seg- 
ments added to the diversity of the K chains. 
The bone marrow sequences are shown in Fig. 1. Of par- 
ticular interest is BM-36,  a V,23,  which only shows 83% 
homology to the closest gene, V~23.32. Therefore, it likely 
represents a new V~23 germline gene. 
As discussed previously (33), it is di~cult to accurately 
assess the extent of V~ family usage in terms of family com- 
plexity since the number of functional genes for most of the 
families is not known. Nevertheless, it is interesting that the 
family estimated to be the largest is V~4,5 (>--16 members), 
and this family was represented most frequently in the bone 
marrow cDNA library (26%). Recently, analysis  ofa genomic 
library of the V~4,5 family (V~Ox) confirms multiple, func- 
tional V~ genes (36). Based upon use of the more specific 
5' V, family probes used by Kalled and Brodeur (33), V~8 
(4-7 members) and V,9 (5-10 members) are also relatively 
large families and are represented prominently in the library 
shown here. In contrast,  V,21  (13 members) and VA9 (5 
members)  were found infrequently.  However,  the splenic 
cDNA libraries analyzed by Kalled and Brodeur (33) for V, 
gene family utilization also showed unexpectedly low fre- 
quencies of V~21 (3.8%).  None of the smaller V, families 
with one, two, or three members were found with unex- 
pectedly high frequencies in the bone marrow library.  In 
general, these data support the lack of bias for particular V~ 
families using the anchored PCR. 
Nonrandom Features of the V~ Bone Marrow Repertoire.  Al- 
though multiple V, families and exons were found in the 
library analyzed, indicating considerable diversity, the utili- 
zation of V~ genes was not random. One member of V,9 
was preferentially used in the bone marrow library. Although 
independent rearrangements were likely in these clones, there 
appeared to be a dear bias for the MOPC41 germline gene, 
the same gene that is used preferentially in the fetal reper- 
toire as described below. Whether this is due to remnants 
of the fetal repertoire in 3-wk-old animals is not clear. How- 
ever, repeats were also observed in other sets of clones, e.g., 
BM-16/BM37 (KL2.21) and BM23n/BMB15  (MRB2), and 
these genes were not found in the fetal libraries. 
Also nonrandom was the utilization  of individual J~ seg- 
ments with J~l  preferentially  used  and J~4  underutilized 
(Table 2). Similar frequencies of the use of individual J, seg- 
ments have been reported by others (33) further validating 
that the anchored PCR approach was not introducing a bias. 
A possible mechanism for the nonrandom use of  JA was re- 
cently reported (37). The DNA binding protein KLP was 
shown to bind at a site 5' of the J,1 segment, an event that 
could target the recombinase to this region and increase the 
frequency of rearrangements  involving JA. 
Restricted v-J, Gene Expression in Fetal Liver.  V~-J~  rear- 
rangements were also examined in 18-d-old fetuses by gener- 
ating a cDNA library from fetal liver using anchored PCR. 
The data are summarized in Table 3 with representative se- 
quences shown in Fig. 2. Most of the sequences are highly 
homologous to  known germline genes.  However,  FL-31 
showed only 96% homology with VA.6 (11 substitutions 
in the coding region). Therefore, FI~31 may represent a new 
V~I germline gene. 
The results indicate a highly restricted V, repertoire in the 
18-d-old fetal liver compared with that observed with 3-wk- 
old bone marrow. In a coUection  of 26 clones, some sequences 
were noted repeatedly. Several families were represented in 
the library including V,4,5,  V~9, VA0, V~8, and V~I, and 
presumably a more extensive library would have revealed ad- 
ditional V, families. However, only one or two members of 
each family were identified,  suggesting  a highly restricted 
repertoire. Even more striking was the repeated use of par- 
ticular  V,-J~ combinations  such as V~9-J~4, VA0-JA,  and 
V~4,5-J,5. This is unlikely to be artifact since the same com- 
binations  found in the fetal library were also found in two 
separate omentum libraries described bdow. Moreover, in sev- 
eral cases among the three libraries, independent rearrange- 
ments could be established. This suggests that these partic- 
ular  V~-J~ joins  are  genetically  favored  or  that  B  cells 
undergoing such rearrangements  are selected. 
Analysis of the v,,-Jx Repertoire in Omentum.  Recent re- 
1322  Biased  K Expression Table  3.  Fetal  Clones 
Clone  V~  J,  Frequency  Percent match  Specificity  Reference 
FL-17 
FL-23 
FL-1 
FL-15 
FL-7  9  4  9/26  98.6-99.3"  Germline,  RBC and  65, 66,  67 
FL-16  (MOPC41,  $2-14.2,  H220-23)*  T cells, hemagglutinin 
FL-12 
FL-25 
FL-26 
FL-13 
FL-4 
FL-32  10  1  6/26  99.6-100  Germline,  V,ArsS,  68,  67 
FL-21  (VlO.lb,  L2-10C1)  hemagglutinin 
FL-18 
FL-11 
FL-29 
FL-6  4,5  5  3/26  99.6-100  Germline,  V~Ox  Jr,  54, 49 
FL-5  (H4, T6-416)  hemagglutinin 
FL-3 
FL-30  4,5  5  3/26  99.6-100  Germline,  V,Ox,  36 
FL-28  (261.CON,  NQ2/6.1)  2-phenyloxazolone 
FL-201  4,5  5  1/26  100  Germline,  V,Ox,  36 
(261.CON,  NQ2/6.1)  2-phenyloxazolone) 
FL-14  1  1  1/26  99.7  Germline,  DNA,  dextran,  31,  59 
(V,1.6,  DNA14, 42-4B-12,  Arsonate 
1210.7) 
FL-31  1  2  1/26  96.3  Germline, DNA,  dextran,  31,  59 
(V~1.6, DNA14, 42-4B-12,  Arsonate 
1270.7) 
FL-2  8  1  1/26  99.6  Hemagglutinin  49 
(T5-626) 
FL-27  8  2  1/26  99.7-100  Hemagglutinin,  55,  56, 25 
(220GL,  NC12-H5-PC3609)  Plasmacytoma 
* Percent homology through the coding regions of the variable gene. 
* Germline designation or hybridoma or call line from which the gene was sequenced and/or cloned. 
$ Germline gene associated with the antiarsonate response. 
II Germline gene associated with the anti-2-phenyl oxazolone response. 
I Two substitutions in J~. 
ports  indicate that  the microenvironment of the the fetal 
omentum supports the development orB cells (4, 38). More 
importantly, the omentum seems to contain precursors that 
exclusively give rise to CD5 + (Bla) and CD5-  (Blb) sister 
B cell subpopulations (4). Therefore, it was interesting to 
compare the V~ repertoire in omentum with that of the fetal 
1323  Medina  and Teale 
liver. For this purpose, two 15-d-old omentum cDNA libraries 
were constructed from fetuses from two separate litters. Day 
15 of gestation was used since this appears to be when the 
amount of B cell lymphopoietic omental tissue is maximal 
(Solvason, N.,  personal communication). There was some 
concern whether K  + cells would be found at this stage since v~9 
FL-17 
FL-15 
OM-713 
-I0  i0 
M  D  M  R  A  P  A  Q  I  F  G  F  L  L  L  L  F  P  G  T  R  C  D  I  Q  M  T  Q  S  P  S  S 
AGC  ATG  GAC ATG  AGG  GCT  CCT  GCA  CAG ATT  TTT  GGC  TTC  TTG  TTG  CTC  TTG  TTT  CCA  GGT ACC  AGA  TGT  GAC  ATC  CAG  ATG  ACC  CAG  TCT  CCA  TCC  TCC 
................................................................................................... 
................................................................................................... 
VKI0  M  I  S  S  A  Q  F  t  G  L  L  L  L  C  F  Q  G  T  R  C  D  I  Q  M  T  Q  T  T  S  S 
FL-18  CTC  AGC  CTG  GAC ATG  ATA  TCC  TCT  GCT  CAG  TTC  CTT GGT  CTC  CTG  TTG  CTC  TGT  TTT  CAA  GGT ACC  AGA  TGT GAT  ATC  CAG  ATG  ACA  CAG ACT  ACA  TCC  TCC 
OM-6  ...................................................................................................... 
0M-1913  ...................................................................................................... 
OM-9  ............................................  A  .........................................  T  ............... 
VK4,5  M  D  F  Q  V  Q  I  F  S  F  L  L  I  S  A  S  V  I  M  S  R  G  Q  I  V  L  T  Q  S  P  A  I 
FL-29  GAC  AGA  ATG  GAT  TTT  CAG  GTG  CAG ATT  TTC AGe  TTC CTG  CTA  ATC  AGT  GCC  TCA  GTC  ATA  ATG  TCC  AGA  GGA CAA  ATT  GTT  CTC  ACC  CAG  TCT  CCA  GCA ATC 
FL-3  ....  A ............  A  ..........................................  C  ......................................... 
FL-20  ....  A ............  A  ..........................................  C  ......................................... 
0M-7  ...................................................................................................... 
OM-913  ....  A ............  A  ...........................................  C  ......................................... 
VKI  M  M  S  P  A  Q  F  L  F  L  L  V  L  W  I  Q  E  T  N  G  D  V  V  M  T  Q  T  P  L  T 
FL-31  TAT  TTC  CTC  AAA  ATG  ATG  AGT  CCT  GCC  CAG  TTC CTG  TTT  CTG  TTA  GTG  CTC  TGG  ATT  CAG  GAA ACC  AAC  GGT  GAT  GTT  GTG  ATG  ACC  CAG  ACT  CCA  CTC  ACT 
FL-14  C  .......................................  C  .................  G  ........................................... 
OM-2213  C  ......................  G  ................  C  .................  G  ........................................... 
VK8  M  E  S  Q  T  Q  V  F  L  S  L  U  L  W  V  S  G  T  C  G  N  v  M  M  T  Q  S  P  S  S 
FL-2  AGG  GGG  ATC  AAG  ATG  GAA  TCA  CAG ACT  CAG GTC  TTC CTC  TCC  CTG  CTG  CTC  TGG  GTA  TCT  GGT  ACC  TGT  GGG AAC  GTT  ATG  ATG  ACA  CAG  TCG  CCA  TCA  TCT 
FL-27  .....  A  -G  .........  T  ......  G-C  .....  T  C-T A-G  -TA  ....  C-  --G  .....................  G--  A  -~  G .....  T  .......  T  .....  C  --c 
OM-III3  .....  A  -G  .........  T  ......  G-C  .....  T  C-T A-G  -TG  ....  C-  --G  .....................  G--  A--  G  .....  T  .......  T  .....  C  --C 
VK9 
FL-17 
FL-15 
0M-713 
eDRI 
20  27 
L  S  A  S  L  G  E  R  V  S  L  T  C  R  A  S  Q  D  I  G  S  S  L  N  W  L  Q  Q 
~A  TCT  GCC  TCT  CTG  GGA  GAA AGA  GTC  AGT  CTC ACT  TGT  CGG GCA AGT  CAG  GAC ATT  GGT AGT  AGC  TTA AAC  ***  ***  ***  ***  ***  ***  TOG  CTT  CAG  CAG 
........................................................................  ***  ***  ***  ***  ***  ***  --T  ......... 
........................................................................  ***  ***  ***  ***  ***  ***  ............ 
VKI0  L  S  A  S  L  G  D  R  V  T  I  S  C  S  A  S  Q  G  I  S  N  Y  L  N  W  Y  Q  Q 
FL-18  CTG  TCT  GCC  TCT  CTG  GGA  GAC AGA  GTC ACC  ATC  AGT  TGC  AGT  GCA AGT  CAG  GC-C ATT  AGC  AAT  TAT  TTA  AAC  ***  ***  ***  ***  ***  ***  TOG  TAT  CAG CAG 
OM-6  ........................................................................  ***  ***  ***  ***  ***  ***  ............ 
OM-1913  ...........................................  T  ............................  ***  ***  ***  ***  ***  ***  ............ 
OM-9  ...........................  G  ............................................  ***  ***  ***  ***  ***  ***  ............ 
vz4.5 
FL-29 
FL-3 
FL-20 
OM-7 
OM-913 
MSASPGEKVTISCSASSSVSYMY  WYQQ 
ATG  TCT  GCA  ~T  CCA  GGG  ~G  ~G  GTC  ACC  ATA  TCC  T~  AGT  GCC AM  T~  AGT  GTA  AGT  TAC ATG  TAC  ***  ***  ***  ***  ***  ***  ***  TOG  TAC  CAG CAG 
................................  G  A ...................................  ***  ***  ***  ***  ***  ***  ***  ............ 
................................  G  A ...................................  ***  ***  ***  ***  ***  ***  ***  ............ 
.....................................................................  ***  ***  ***  ***  ***  ***  ***  ............ 
...........  A  ....................  G  A ...................................  ***  ***  ***  ***  ***  ***  ***  ............ 
VKI  L  S  V  T  I  G  Q  P  A  S  I  S  C  K  S  S  Q  S  L  L  Y  S  N  G  K  T  Y  L  N  W  L  L  Q 
FL-31  TTG  TCG  GTT  ACC  ATT  GGA  CAA CCA  GCC  TCT  ATC  TCT  TGC  AAG  TCA AGT  CAG AGC  CTC  TTA  TAT AGT  AAT  GGA  AAA  Ace  TAT  TTG  /&AT *** TOG  ~A  TTA CAG 
FL-14  ....................  T  ........  C  ..............................  G  .....  G  .......  G  --A  .........  ***  .....  G  ...... 
0M-2213  ....................  T  ........  C  ..............................  G  .....  G  .......  G  --A  .........  ***  .....  G  ...... 
VK8  L  A  V  S  A  G  E  K  V  T  M  S  C  K  S  S  Q  S  V  L  Y  G  S  N  Q  K  N  Y  L  A  W  Y  Q  Q 
FL-2  CTG  GCT  GTG  TCT  GCA  GGA  GAA AAG  GTC ACT  ATG  AGC  TGT  AAG  TCC AGT  CAA AGT  GTT  TTA  TAC  GGT  TCA AAT  CAG  AAG  AAC  TAC  TrG  GCC  TGG  TAC  CAG  CAG 
FL-27  --A  ........  A  -TT  .....  G  .....  T  ...........  C  ...........  G  --C C  .......  T  A--  AGe  .....  A  ........................... 
0M-1113  --A  ........  A  -TT  .....  G  .....  T  ...........  C  ...........  G  --C C .......  T  A--  AGC  .....  A  ........................... 
VK9 
FL-17 
FL-15 
OM-713 
CDR2 
40  50  60  70 
E  P  D  G  T  I  K  R  L  I  Y  A  T  S  S  L  D  S  G  V  P  K  R  F  S  G  S  R  S  G  S  D  Y  S 
GAA CCA  GAT  GGA ACT  ATT  AAA  CGC  CTG ATC  TAC  GCC ACA  TCC AGT  TTA  GAT  TCT  GGT  GTC  CCC AAA  AGG  TTC AGT  GGC  AGT AGG  TCT  GGG  TCA  GAT  TAT  TCT 
.....................................................................  C  ................................ 
...................................................................................................... 
V~I0  K  P  D  G  T  V  K  L  L  I  Y  Y  T  S  S  U  H  S  G  V  R  S  R  F  S  G  S  G  3  G  T  D  Y  S 
FL-18  AAA  CCA  GAT  GGA ACT  GTT  AAA  CTC  CTG  ATC  TAT  TAC ACA  TCA AGT  TTA  CAC  TCA  GGA  GTC  CCA  TCA  AGG  TTC AGT  GGC  AGT  GGG  TCT  GGG  ACA  GAT  TAT  TCT 
OM-  6  ...................................................................................................... 
0M-1913  ......................................  G  ............................................................... 
OM-  9  ...................................................................................................... 
VK4,5  R  P  G  S  S  P  K  ~  W  I  Y  R  T  S  N  L  A  S  G  V  P  A  R  F  S  G  S  G  S  G  T  S  Y  S 
FL-29  AGG  CCA  GGA TCC  TCC  CCC  AAA  CCC  TGG  ATT  TAT  CGC  ACA  TCC AAC  CTG  GCT  TCT  GGA  GTC  CCT  GCT  CGC TTC AGT  GGC  AGT  GGG  TCT  GGG  ACC  TCT  TAC  TCT 
FL-3  -A  .................  G-  -T-  CT  .......  GA  .............................  T  ..................................... 
FL-20  -A  .................  G-  -T-  CT  .......  GA  .............................  T  ..................................... 
OM-7  -A  .................................................................................................... 
0M-913  -A  .................  G-  -T  ..........  GA  .............................  T  ..................................... 
VKI  R  P  C  Q  S  P  K  R  L  I  Y  L  V  S  K  L  D  S  G  V  P  D  R  F  T  G  S  G  S  G  T  D  F  T 
FL-31  AGG  CCA  C,C-C  CAG  TCT  CCA  AAG  CGC  CTA ATC  TAT  CTG GTG  TCT AAA  CTG  GAC  TCT  GGA  GTC  CCT  GAC AGG  TTC ACT  GGC  AGT  GGA  TCA  GGA ACA  GAT  TTT  ACA 
FL-14  ..........................................................................................  G  ........  C  --- 
0M-2213  .........................................................................................  G  ........  C  --- 
VK8  K  P  G  Q  S  P  K  L  L  I  Y  W  A  S  T  R  E  S  G  V  P  D  R  F  T  G  S  G  S  G  T  D  F  T 
FL-2  AAA  CCA GGG  CAG  TCT  CCT  AAA  CTG  CTG  ATC  TAC  TGG  GCA  TCC ACT  AGG  GAA  TCT  GGT  GTC  CCT  GAT  CGC TTC ACA  GGC  AGT  GGA  TCT  GGG  ACA  GAT  TTT  ACT 
FL-27  .............................  T  ..........................  G  .........................................  C  --- 
OM-I113  .............................  T  ..........................  G  .........................................  C  --- 
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L  T  I  S  S  L  E  S  E  D  F  V  D  Y  Y  C  L  Q  Y  A  S  S  P  P  F  T  F  G 
FL-17  CTC  ACC  ATC  AGC  AC-C  CTT  GAG  TCT  GAA  GAT  TTf  GTA  GAC  TAT  TAC  TGT  CTA  CAA  TAT  GCT  AGT  TCT  CCC  CCA  TTC  ACG  TTC GGC  Jk4 
FL-15  ....................................................................................  Jk4 
OM-713  ....................................................................................  Jk4 
v~1o 
FL-18 
OM-6 
L  T  I  S  N  L  E  P  E  D  I  A  T  Y  Y  C  Q  Q  Y  S  K  L  P  W  T  F  G 
CTC  ACC  ATC  AGC  AAC  CTG GAA  CCT  GAA  GAT ATT  GCC ACT  TAC  TAT  TGT  CAG  CAG TAT  AGT  AAG  CTT  CCG  ***  TGG  ACG  TTC  GGT 
.....................................................................  ***  ............ 
OM-1913  .....................................................................  ***  ............ 
OM-9  ......................................  C  ..............................  ***  ............ 
Jkl 
Jkl 
JKI 
Jkl 
VK4,5  L  T  I  S  S  M  E  A  E  D  A  A  T  Y  Y  C  Q  Q  Y  H  S  Y  P  L  T  F  G 
FL-29  CTC  ACA  ATC  AGC  AGC ATG  GAG  GCT  GAA  GAT  GCT  GCC ACT  TAT  TAC  TGC  CAG  CAG TAT  CAT AGT  TAC  CCA  *** CTC  ACG  TTC  GGT  Jk5 
FL-3  ............  C-A  ........................................  GG AG  .........  G  ***  ............  Jk5 
FL-20  ............  C-A  ........................................  GG AG  .........  G  ***  ........  T  A--  Jk5 
OM-7  .....................................................................  ***  ............  Jk5 
0M-913  ............  C-A  ........................................  GG AG  .........  G  ***  ............  Jk5 
VKI  L  K  I  S  R  V  E  A  E  D  L  G  V  Y  Y  C  V  Q  G  T  H  F  P  Y  T  F  G 
FL-31  CTG  AAAATC  AGC  AGA  GTG  GAG  GCT  GAG  GAT  TTG  GGA  GTT  TAT  TAC  TGC  GTG  CAA  GGT ACA  CAT  TTT  CCG  *** TAC  ACG  TTC  GGA  Jk2 
FL-14  ............................................  T  ---  TG  ..................  T  *** CGG  ........  T  Jkl 
0M-2213  ............................................  T  ---  TG  ..................  T  *** CGG  ........  T  Jkl 
VK8  L  T  I  S  S  V  Q  A  E  D  L  A  V  Y  Y  C  H  Q  Y  L  S  S  W  T  F  G 
FL-2  CTT ACC  ATC  AGC AGT  GTA  CAA  GCT  GAA  GAC  CTG  GCA  GTT  TAT  TAC  TGT  CAT  CAA  TAC  CTC TCC  TCG  ***  *** TGG  ACG  TTC  GGT  Jkl 
FL-27  --C  ..............  G  A-G  .............................  G  .....  T  TAT AG-  -AT  CCG  ***  -AC  ........  A  Jk2 
0M-II13  --C  ..............  G  A-G  .............................  G  .....  T  TAT AG-  -AT  CCG  ***  -AC  ........  A  Jk2 
Figure 2.  V, sequences  of selected 18-d-old fetal liver and 15-d-old omentum  cDNA clones. For a description  of the symbols, see legend of Fig. 1. 
slg §  cells  were absent at day 13  (4).  However, slg §  cells 
were detected in human omentum at 8-12 wk of gestation 
(38). Moreover, a significant PCR reaction was obtained using 
the C, primer for both libraries.  Further amplification was 
not required for either library. 
The data obtained from the omentum is shown in Table 
4 and Fig. 2. Since the sequence obtained with both libraries 
were  similar,  the  data  were  combined.  The  V~  families 
identified have been found previously in known CD5 + cells 
including  V,9  and  V~4,5  which  are predominant  in  the 
bromelain-RBC/phosphatidyl choline reactivity (39, 40). In 
general, a similar V, repertoire was observed using the fetal 
omentum and fetal liver libraries.  The same set of restricted 
V,  exons were repeatedly used.  Moreover, identical V,-J, 
combinations were identified with VA0-JA, V~4,5-J~5, and 
V~9-J~4  recombinations  dominating.  JK  usage  in  the 
omentum library is different from that of the bone marrow 
library with increased use of J~4 and J~5 and decreased use 
of  JK2  (Table  2).  The  results  of  V~-J~ usage  indicate 
significant overlap of the fetal omentum and fetal liver reper- 
toires.  Similarities  in  the B  cell compartments of human 
omentum and fetal liver were also  noted by Solvason  and 
Kearney (38).  This would be consistent with previous con- 
clusions that B cells in early development are dominated by 
CD5 + B cells  including the fetal liver (15).  However, we 
have also begun analyzing the V, repertoire of the omentum 
using the same omental RNA used here to generate cDNA 
V~ libraries.  Initial results indicate that the omental V. li- 
brary may be more restricted than the fetal liver library (Teale, 
J.,  and E. J.  Morris,  manuscript in preparation). 
Diversity at the v~-J~Junction.  Diversity at the V-J junc- 
tion is  mainly the result of exonuclease activity with  the 
removal of bases at either V or J. This introduces variability 
in the CDR3  even when identical VK-JK combinations are 
used. Residues located 3' of the V~ exon appear to be used 
sometimes during recombination to create a longer CDR3 
(36).  A probable example of this is BM-16 (Fig.  1) and the 
FL  and  OM  sequences (Fig.  2)  of VK9 (MOPC41).  This 
results in an extra Pro at position 96.  An analysis  of junc- 
tional diversity was used, in part, to establish independent 
rearrangements in the sequences shown here. 
Milstein et al. (36) recently analyzed a genomic library of 
V~4,5 rearrangements in adult spleen and found evidence for 
asymmetric trimming with more bases being removed from 
V than from J. In the sequences shown here where the germ- 
line VK sequence could be clearly identified, some degree of 
asymmetry was found as well (Table  5). 
Evidence has also been reported for the addition of bases 
at the VL-JL  junction through N or P residues (36, 41). BM- 
17N may represent one such example. The CDR3  of this 
clone appeared to lack the highly conserved Pro at position 
95 and contained only eight amino acid residues.  A close in- 
spection of the V-J junction in this sequence showed two 
residues, TC, that do not seem to originate from the V or J 
genes. However, if this does represent nontemplated addition 
of nucleotides, it is rare for L chains as noted elsewhere (41). 
Importantly, the H  chain CDR3  of fetal/neonatal anti- 
bodies has been shown to be shorter than adult-derived anti- 
bodies. This is due to lack of N insertions as well as targeted 
rearrangements in early development involving homologous 
overlapping sequences (12-14).  In the case of the fetal ~ se- 
quences, there may be slightly less trimming of bases  at J 
during V-J joining compared with the bone marrow (Table 
5). However, the average lengths of the L chain CDR3s are 
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Clone  V~  J~  Frequency  Percent match  Specificity  Reference 
OM-5 
OM-6 
OM-3 
OM-1313 
OM-513" 
OM-19131t 
OM-91 
OM-1613"* 
10  1  4/22  99.3-100"  Germline,  V~Ars  s  68, 67 
(V10.1b,  L2-10C1)*  Hemagglutinin 
10  1  2/22 
10  1  1/22 
10  1  1/22 
OM-13 
OM-2313  4,5  5  3/22 
OM-7 
OM-46  4,5  5  4/22 
OM-913 
OM-813 
OM-1713 
OM-1413SS  4,5  5  1/22 
OM-713 
OM-1513  9  4  4/22 
OM-313 
OM-8 
OM-2213  1  1  1/22 
0M-1113  8  2  1/22 
99.3  Germline,  V~Ars,  68,  67 
(V~10.1b, L2-10C1)  Hemagglutinin 
98.9  Germline,  V~Ars,  68,  67 
(V10.1b-L2-10C1)  Hemagglutinin 
99.3  Germline,  VKArs,  68,  67 
(VA0.1b,  L2-10C1)  Hemagglutinin 
99.6-100  Germline,  VKOx**,  54, 49 
(H4, T6-416)  Hemagglutinin 
99.6-100  Germline,  V~Ox,  36 
(261.CON,  NQ2/6.1)  2-phenyloxazolone 
100 
(261.CON,  NQ2/6.1) 
98.6-99.3 
(MOPC41,  $2-14.2,  H220-23) 
Germline,  V~Ox, 
2-phenyloxazolone 
Germline,  RBC and 
T cells, hemagglutinin 
99.3  Germline,  DNA,  dextran, 
(V~1.6, DNA14, 42-4B-12  arsonate 
12.10.7) 
99.7-100  Hemagglutinin, 
(220GL, NC12-H5,  Plasmacytoma 
PC3609) 
36 
65, 66, 67 
31,  59 
55,  56,  25 
* Percent homology through the coding regions of the variable gene. 
* Germline designation or hybridoma or plasmacytoma from which the gene was cloned and/or sequenced. 
S  Germline gene associated with the antiarsonate response. 
II One replacement in the CDR1; one silent mutation in the CDR2. 
￿82  One replacement in the FR1; two silent mutations in the FR.1 and FR3. 
**  Designated as a nonproductive rearrangment. 
** Germline gene associated with the anti-2-phenyloxazole  response. 
SS Two substitutions in J~, same as FL-20. 
essentially identical in all of the libraries analyzed arguing 
against major differences in junctional diversity. Selection may 
also  contribute to these minor differences. 
/c Gene Expression in Early Ontogeny.  No sequences from 
the  V~21 family,  the  most  J-proximal  family  (18),  were 
identified in the fetal libraries. This is consistent with previous 
results indicating relatively low or no V~21 family expres- 
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sion in LPS-stimulated fetal and neonatal B cells  (29,  30). 
Instead, several families are expressed that appear to be spread 
throughout  the  K locus.  This  argues  against  a  position- 
dependent regulation of V~ gene expression as has been ar- 
gued for V. gene usage (7).  (It should be noted however, 
that constraints independent of  mapping position appear likely 
in H  chain gene rearrangement (11, 13, 42, 43]). The lack Table  5.  Analysis of Junctional Diversity 
Bone marrow  Fetal liver  Omentum 
Range of no. of nucleotides 
removed* 
Average no. of nucleotides 
removed/sequence analyzed 
Average length of CDR3 
V:0-5 J:0-1  V:0-5 J:0-1  V:0-5 J:0-1 
(17)*  (23)  (20) 
V:2.8 J:0.23  V:2.3 J:0.04  V:3.0 J:0.05 
(17)  (23)  (20) 
8.7  9.3  9.2 
(27)  (26)  (22) 
* For sequences  when the germline V~ was known,  the number of bases  trimmed from either V  or J  was determined. 
* Number of sequences  analyzed. 
of any evidence for position-dependent effects may relate to 
the fact that over 40% of the V~ genes appear to be in the 
opposite transcriptional  orientation from J~ and rearrange by 
inversion (22).  Importantly, with the exception of V~I, all 
of the fetal sequences identified here are from V~ families 
known to rearrange by inversion (22).  Moreover,  in some 
cases the individual members used have been indicated to 
rearrange by inversion,  i.e.,  V~9-MOPC41  (24)  and V~8- 
PC3609  (25).  Two of the  three  known functional VK10 
members rearrange by inversion (22). The mechanism of rear- 
rangement for  the  third  member is  not  known.  Several 
members of the VK4,5 family also rearrange by inversion (22, 
26, 44).  This suggests that the early K repertoire is domi- 
nated by inversion-type rearrangements. 
Also likely to be biologically important is the apparent 
preference  for  particular  V~-J~ combinations in  the  fetal 
repertoire. This is particularly striking since some of the same 
VK exons are found in the bone marrow library with mul- 
tiple J~  exons.  Given  their  frequency  in  three  different 
libraries, they presumably represent primary rearrangements. 
Interestingly, Kalled and Brodeur (44) recently reported on 
K rearrangements in A-MuLV-transformed pre-B cell lines in 
which 84% resulted in a V~4,5-J~5 recombination, one of 
the predominant rearrangements observed here. It has been 
suggested that primary inversion rearrangements may make 
5' V~ exons more accessible for secondary rearrangements 
(22,  44).  However,  recombination to J~5  would prevent 
functional secondary rearrangements. Similarly, the V~9-J~4 
would significantly limit secondary rearrangements particu- 
larly given the 5' location of V~9. Moreover,  the repeated 
identification of V~10-J~l rearrangement in plasmacytomas/ 
cell lines (22) suggests that this may also represent a stable 
recombination event less prone to functional secondary rear- 
rangements. Since secondary K rearrangements are thought 
to provide another mechanism for Ig diversity and increase 
chances for effective H and L chain pairing (27), a limitation 
on secondary rearrangements would result in a more restricted 
fetal repertoire. 
Several lines of evidence indicate that the H chain fetal reper- 
toire is significantly restricted compared with the adult reper- 
toire.  These include biased usage of particular V,, D,  and 
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J. exons, a preferred D reading frame, and lack of  junctional 
diversity (for a review see reference 1). The relative role of 
developmental, functional, and evolutionary pressures on the 
early repertoire remain unclear. It has been argued by many 
that a highly conserved early repertoire would effectively  coun- 
teract ubiquitous bacterial  pathogens (45).  The propensity 
for self-reactivities also suggests an immunoregulatory role 
(46, 47). A conserved repertoire would necessitate restricted 
L as well as H  chain diversity. L chains have recently been 
shown to contribute significantly  to the fine specificity of 
antibodies.  For example, the H9 heavy chain used in anti- 
DNA antibodies wiU also react with other antigens such as 
cardiolipin/RNA depending upon the L chain with which 
it pairs (48). Also of interest are recent molecular studies of 
the influenza hemagglutinin (HA) antigen system in which 
the antibody response to slight changes in a HA epitope were 
analyzed (49). It was shown that the altered epitope was ac- 
commodated in the antibody response, not by changes in the 
CDR3, but rather by changes in H and L chain pairing. There- 
fore, if there is evolutionary pressure to restrict the early reper- 
toire, limitation at the L chain level is probably critical. Part 
of this limitation may be imposed at the genetic level Fetal 
H chain expression is restricted and the lengths of the CDR3 
significantly shorter. This may limit the number of L chains 
that can effectively pair with the fetal H chains. The ability 
to achieve H  and L chain pairing may also underlie the ob- 
served V~-J~ preferences. 
Results of a highly restricted fetal K  repertoire also impact 
on theories of selection and clonal expansion. H chain rear- 
rangement normally precedes L chain rearrangement (1-3), 
although exceptions have been reported (50).  This appears 
to be true of all stages of development since pre-B cells ante- 
date B cells. In bone marrow, it appears that pre-B cells are 
clonally  expanded  perhaps  by  selection  through  the  H 
chain-surrogate L chain complex (51, 52). The expanded ceils 
then appear to independently  rearrange L chain genes resulting 
in a diverse set of B cells (51, 53).  This is consistent with 
our bone marrow library where multiple K rearrangements 
were found. However,  given the highly restricted, repeated 
sequences in the three fetal libraries shown here, and the likeli- 
hood that H chain rearrangement precedes L chain rearrange- ment, it appears that clonal expansion/selection in the early 
repertoire occurs after L chain gene rearrangement.  Aherna- 
tively, fetal B lineage cells may expand at both the pre-B cell 
and B cell stages. Expansion at the B cell level would further 
restrict the fetal repertoire by increasing the number of cells 
with identical H and L chain pairs.  It also indicates a unique 
donal sdection/expansion mechanism for the early repertoire. 
In summary, the early repertoire is restricted in terms of 
both H  and L chain expression.  The available  data do not 
allow definitive conclusions to be drawn as to whether the 
underlying mechanisms involve primarily genetic forces, en- 
vironmental  forces, or a combination of both.  Fetal pre-B 
cells  develop in  vitro  with  a fetal-like  V.  repertoire  even 
when  supported by adult bone marrow  stromal cells (11). 
This, combined with lack of TdT and differences in CDK3s 
(1) suggest that at least some of the differences between fetal 
and adult repertoires are due to distinct progenitors and rear- 
rangement  strategies. The restriction in L chain expression 
shown here may also be due, in part, to genetic mechanisms. 
Certain V~-J, recombinations may be preferred. In addition, 
L chain expression may be restricted on the basis of the ability 
to pair with a more limited fetal H  chain repertoire.  Sdec- 
tion mechanisms may also be operative. Once L chain rear- 
rangement  and expression occurs in fetal B cells,  there ap- 
pears  to  be  considerable  expansion,  perhaps  by  sdection 
through  the intact  Ig receptor.  The end result is a highly 
conserved fetal repertoire. 
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